Status:
UNKNOWN
Urinary T Cell Biomarker for Prediction in Lupus Nephritis
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Berlin Institute of Health
Conditions:
Lupus Nephritis
Eligibility:
All Genders
18+ years
Brief Summary
Urinary T-lymphocytes may be predictive for clinical outcome in patients with lupus nephritis. The investigators hypothesize that the amount of CD4+ effector/memory T-cells in urine at time of diagnos...
Eligibility Criteria
Inclusion
- Biopsy proven lupus nephritis
- In absence of a biopsy a SLEDAI of at least 10 \& at least two renal elements of the renal SLEDAI (rSLEDAI)
- Informed consent
- Diagnosis of SLE according to the American College of Rheumatology (ACR) criteria
Exclusion
- Biopsy-proven non-SLE related disease
- Urinary tract infection
- Active menstrual bleeding
- Kidney transplantation during observation time
Key Trial Info
Start Date :
July 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT04320797
Start Date
July 30 2019
End Date
September 1 2022
Last Update
March 9 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany, 10117
2
The Royal Free London
London, United Kingdom, NW3 2QG